Antiretroviral news from ICAAC 2000.
J E
JE
Gallant
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D004334:Drug Administration Schedule; D004351:Drug Resistance; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D061466:Lopinavir; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D000068698:Tenofovir
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011744:Pyrimidinones; D061466:Lopinavir; D000068698:Tenofovir; D000225:Adenine; D019438:Ritonavir